• Company News: Merck (MRK) Q2 results beat analysts’ expectations

Market news

28 July 2017

Company News: Merck (MRK) Q2 results beat analysts’ expectations

Merck (MRK) reported Q2 FY 2017 earnings of $1.01 per share (versus $0.93 in Q2 FY 2016), beating analysts' consensus estimate of $0.87.

The company's quarterly revenues amounted to $9.930 bln (+0.9% y/y), beating analysts' consensus estimate of $9.746 bln.

MRK rose to $64.48 (+1.24%) in pre-market trading.

Market Focus
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer
Open Demo Account & Personal Page
I understand and accept the Privacy Policy and agree to my name and contact details being used by TeleTrade to contact me about this.